VRAI vs. BBC
VRAI (Virtus Real Asset Income ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both exchange-traded funds - VRAI is a REIT fund tracking the Indxx Real Asset Income Index, while BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 5 years, VRAI returned 5.71%/yr vs -0.26%/yr for BBC. At a 0.38 correlation, their price movements are largely independent. VRAI charges 0.55%/yr vs 0.79%/yr for BBC.
Performance
VRAI vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VRAI achieves a 20.17% return, which is significantly lower than BBC's 25.75% return.
VRAI
- 1D
- 0.52%
- 1M
- -1.36%
- YTD
- 20.17%
- 6M
- 20.99%
- 1Y
- 22.60%
- 3Y*
- 12.35%
- 5Y*
- 5.71%
- 10Y*
- —
BBC
- 1D
- 1.59%
- 1M
- 13.54%
- YTD
- 25.75%
- 6M
- 22.73%
- 1Y
- 156.95%
- 3Y*
- 27.00%
- 5Y*
- -0.26%
- 10Y*
- 11.15%
VRAI vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VRAI Virtus Real Asset Income ETF | 20.17% | 6.67% | 2.66% | 6.12% | -9.96% | 24.35% | -5.94% | 6.05% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 25.75% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 51.68% |
Correlation
The correlation between VRAI and BBC is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Feb 8, 2019 | 0.38 |
Over the past year, the correlation between VRAI and BBC has dropped to 0.08 - well below their long-term average of 0.38, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRAI vs. BBC — Risk / Return Rank
VRAI
BBC
VRAI vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus Real Asset Income ETF (VRAI) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VRAI | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.46 | ||
| Sortino ratioReturn per unit of downside risk | -1.99 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.56 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 4.71 | 10.46 | -5.75 |
| Martin ratioReturn relative to average drawdown | 14.54 | 30.65 | -16.11 |
Loading charts...
Drawdowns
VRAI vs. BBC - Drawdown Comparison
The maximum VRAI drawdown since its inception was -47.51%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for VRAI and BBC.
Loading charts...
Drawdown Indicators
| VRAI | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.51% | -76.85% | +29.34% |
Max Drawdown (1Y)Largest decline over 1 year | -4.82% | -15.10% | +10.28% |
Max Drawdown (3Y)Largest decline over 3 years | -16.89% | -54.45% | +37.56% |
Max Drawdown (5Y)Largest decline over 5 years | -26.71% | -71.97% | +45.26% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.85% | — |
Current DrawdownCurrent decline from peak | -2.34% | -19.28% | +16.94% |
Average DrawdownAverage peak-to-trough decline | -10.03% | -37.08% | +27.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.56% | 5.14% | -3.58% |
Volatility
VRAI vs. BBC - Volatility Comparison
The current volatility for Virtus Real Asset Income ETF (VRAI) is 3.28%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 12.08%. This indicates that VRAI experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VRAI | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.28% | 12.08% | -8.80% |
Volatility (6M)Calculated over the trailing 6-month period | 8.29% | 26.79% | -18.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 11.99% | 36.27% | -24.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.61% | 39.52% | -22.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.07% | 37.75% | -15.68% |
VRAI vs. BBC - Expense Ratio Comparison
VRAI has a 0.55% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
VRAI vs. BBC - Dividend Comparison
VRAI's dividend yield for the trailing twelve months is around 2.92%, more than BBC's 1.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.35% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
VRAI Virtus Real Asset Income ETF | 2.92% | 4.68% | 7.13% | 5.02% | 4.48% | 3.34% | 3.91% | 2.80% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
VRAI and BBC have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (12.08%) compared to VRAI (3.28%). In terms of maximum drawdown, VRAI dropped -47.51% vs BBC's -76.85%.
On 5-year performance, VRAI leads with 5.71% vs -0.26% for BBC. On fees, VRAI is cheaper at 0.55% per year. On volatility, VRAI has been the lower-risk option at 3.28%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VRAI has performed better with a 5.71% return vs -0.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VRAI is cheaper with a 0.55% expense ratio, compared with 0.79% for BBC.
VRAI has the higher dividend yield at 2.92%, compared with 1.35% for BBC.
VRAI is categorized as REIT, while BBC is Health & Biotech Equities. VRAI tracks Indxx Real Asset Income Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. Their fees differ too: 0.55% for VRAI and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (4.36 vs 1.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VRAI and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer